Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DEFERASIROX vs VEMURAFENIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DEFERASIROX vs VEMURAFENIB: Safety Overview

Metric DEFERASIROX VEMURAFENIB
Total FAERS Reports 11,322 8,562
Deaths Reported 2,661 1,040
Death Rate 23.5% 12.1%
Hospitalizations 4,008 2,368
Average Patient Age 49.8 yrs 58.1 yrs
% Female Patients 50.1% 45.7%
FDA Approval Date Apr 11, 2025 Aug 17, 2011
Manufacturer AvKARE Genentech, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription